相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes
Stefanie Eising et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Arresting type 1 diabetes after diagnosis: GAD is not enough
Chantal Mathieu et al.
LANCET (2011)
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial
Nicole Sherry et al.
LANCET (2011)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
Humanizing Animal Models: A Key to Autoimmune Diabetes Treatment
Damien Bresson et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Human CD3 Transgenic Mice: Preclinical Testing of Antibodies Promoting Immune Tolerance
Chantal Kuhn et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients
Bart Keymeulen et al.
BLOOD (2010)
Caspase Inhibitor Therapy Synergizes With Costimulation Blockade to Promote Indefinite Islet Allograft Survival
Juliet A. Emamaullee et al.
DIABETES (2010)
Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes
Ping Xu et al.
DIABETES CARE (2010)
Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New-Onset Type 1 Diabetes
Peter A. Gottlieb et al.
DIABETES CARE (2010)
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients
E. Vandemeulebroucke et al.
DIABETOLOGIA (2010)
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
B. Keymeulen et al.
DIABETOLOGIA (2010)
Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
Geoff Hale et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus
Pawel Wiczling et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints
Junko Nishio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study
Christopher C. Patterson et al.
LANCET (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes
M. D. Bellin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Restoring a functional β-cell mass in diabetes
D. Pipeleers et al.
DIABETES OBESITY & METABOLISM (2008)
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
Kirsti Nanto-Salonen et al.
LANCET (2008)
Essential roles of TGF-β in anti-CD3 antibody therapy:: reversal of diabetes in nonobese diabetic mice independent of Foxp3+ CD4+ regulatory T cells
Guojiang Chen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes
Markus Feuerer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment
Sylvaine You et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes
T. Staeva-Vieira et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Cellular and molecular pathogenesis of type 1A diabetes
M. M. Jahromi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients
Manuela Battaglia et al.
JOURNAL OF IMMUNOLOGY (2006)
Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft
Bart Keymeulen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
International trial of the edmonton protocol for islet transplantation
A. M. James Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transforming growth factor-β and T-cell-mediated immunoregulation in the control of autoimmune diabetes
Sylvaine You et al.
IMMUNOLOGICAL REVIEWS (2006)
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells
Danila Valmori et al.
JOURNAL OF IMMUNOLOGY (2006)
Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs
D Bresson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
JM Sosenko et al.
DIABETES CARE (2006)
Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse
SA Nanji et al.
DIABETES (2006)
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
B Bisikirska et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A comprehensive review of interventions in the NOD mouse and implications for translation
LKM Shoda et al.
IMMUNITY (2005)
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience
T Froud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects - A 16-month, randomized, comparative trial
JS Skyler et al.
DIABETES CARE (2005)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
KC Herold et al.
DIABETES (2005)
Treatment with nomnitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis
AP Kohm et al.
JOURNAL OF IMMUNOLOGY (2005)
Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes
K Decochez et al.
DIABETOLOGIA (2005)
European Nicotinamide Diabetes Intervention Trial (ENDIT):: a randomised controlled trial of intervention before the onset of type 1 diabetes
EAM Gale et al.
LANCET (2004)
Engaged and bystander T cell receptors are down-modulated by different endocytotic pathways
A Monjas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Constitutive and ligand-induced TCR degradation
M von Essen et al.
JOURNAL OF IMMUNOLOGY (2004)
The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes
KM Gillespie et al.
LANCET (2004)
Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants
SP Cobbold et al.
JOURNAL OF IMMUNOLOGY (2004)
TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
M Belghith et al.
NATURE MEDICINE (2003)
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody
RT Meijer et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Intranasally administered insulin intended for prevention of type 1 diabetes -: a safety study in healthy adults
A Kupila et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab
V Baudouin et al.
TRANSPLANTATION (2003)
CD3-specific antibody-induced active tolerance: From bench to bedside
L Chatenoud
NATURE REVIEWS IMMUNOLOGY (2003)
IA-2 autoantibodies predict impending Type I diabetes in siblings of patients
K Decochez et al.
DIABETOLOGIA (2002)
Identification of regulatory T cells in tolerated allografts
L Graca et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Ligand-induced TCR down-regulation is not dependent on constitutive TCR cycling
J Dietrich et al.
JOURNAL OF IMMUNOLOGY (2002)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease
PA Carpenter et al.
BLOOD (2002)
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases
Jean-Francois Bach
ARTHRITIS RESEARCH & THERAPY (2002)
Pharmacokinetics of murine anti-human CD3 antibodies in man are determined by the disappearance of target antigen
RT Meijer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Anti-CD3ε F(ab′)2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens
XZ Yu et al.
JOURNAL OF IMMUNOLOGY (2001)
HuM291 (NUVION), a humanized Fc receptor-nonbinding antibody against CD3, anergizes peripheral blood T cells as partial agonist of the T cell receptor
LA Chau et al.
TRANSPLANTATION (2001)
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors
DJ Norman et al.
TRANSPLANTATION (2000)
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
PA Carpenter et al.
JOURNAL OF IMMUNOLOGY (2000)
On the dynamics of TCR:CD3 complex cell surface expression and downmodulation
HY Liu et al.
IMMUNITY (2000)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenetic anti-CD3ε F(ab′)2
XZ Yu et al.
TRANSPLANTATION (2000)
分享论文
